Vetoquinol chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 45.37
Dividend & YieldN/A£ (N/A)
Beta 0.87
Market capitalization 9.8M
Operating cash flow 45.76M
ESG Scores unknown

Company description

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Sector: - Industry:

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 16.44M
Total Cashflows From Investing Activities -17.75M -64.55M -145.14M -33.45M
Net Borrowings -8.67M -8.81M 111.98M -109.03M
Total Cash From Financing Activities -15.2M -20.12M 101.99M -120.85M
Change To Operating Activities -10.91M 722k 21.43M -1.74M
Issuance Of Stock
Net Income 36.26M 28.59M 19.22M 62.86M
Change In Cash 4.58M -33.99M 45.75M -61.22M
Effect Of Exchange Rate -360k -1.35M -3.32M 3.36M
Total Cash From Operating Activities 37.88M 52.02M 92.23M 89.72M
Depreciation 11.74M 17.61M 24.37M 31M
Change To Account Receivables 4.21M 4.21M 4.21M 4.21M
Other Cashflows From Financing Activities -91k -5.11M -5.26M -5.91M
Change To Netincome -232k 3.44M 25.47M -2.38M
Capital Expenditures -11.28M -9.45M -10.34M -13.82M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 48.4M 40.71M 35.87M 86.64M
Net Income 36.26M 28.59M 19.22M 62.86M
Selling General Administrative 135M 138.76M 147.13M 176.09M
Gross Profit 196.03M 205.89M 233.54M 292.64M
Ebit 48.27M 45.98M 56.35M 81.75M
Operating Income 48.27M 45.98M 56.35M 81.75M
Interest Expense -190k -382k -827k -617k
Income Tax Expense 12.17M 12.46M 16.64M 23.77M
Total Revenue 367.94M 395.99M 427.47M 521.27M
Cost Of Revenue 171.91M 190.1M 193.93M 228.63M
Total Other Income ExpenseNet 123k -5.27M -20.48M 4.9M
Net Income From Continuing Ops 36.23M 28.25M 19.23M 62.87M
Net Income Applicable To Common Shares 36.26M 28.59M 19.22M 62.86M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 102.5M 125.49M 274.26M 183.21M
Total Stockholder Equity 363.1M 386.35M 371.75M 441.26M
Other Current Liabilities 23.25M 26.11M 44.9M 57.81M
Total Assets 465.58M 511.47M 646.09M 624.56M
Common Stock 29.7M 29.7M 29.7M 29.7M
Other Current Assets 1.36M 1.54M
Retained Earnings 36.26M 28.59M 19.22M 62.86M
Treasury Stock 256.01M 286.93M 281.69M 307.57M
Cash 117.63M 84.51M 129.44M 69M
Total Current Liabilities 84.14M 92.71M 239.55M 157.03M
Other Stockholder Equity 256.01M 286.93M 281.69M 307.57M
Property, Plant, and Equipment 56.18M 70.74M 72.27M 72.99M
Total Current Assets 274.1M 257.32M 307.16M 273.69M
Net Tangible Assets 239.52M 213.96M 116.89M 179.28M
Net Receivables 75.16M 91.35M 88.65M 87.25M
Accounts Payable 25.65M 30.45M 41.47M 46.94M


Insider Transactions

Here are the insider transactions of stock shares related to Vetoquinol:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Vetoquinol. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Vetoquinol

Here is the result of two systematic investment strategies applied to Vetoquinol. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Vetoquinol

The following chart shows the equity curve of the two systematic investment strategies applied to Vetoquinol:

Vetoquinol automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0.0% on the backtest period.

Performance at glance

Performance

0.0 %

Latent gain

0.0 £

Invested capital

296.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Vetoquinol

This is the result of two momentum investment strategies applied to Vetoquinol. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Vetoquinol

The following chart shows all the entries opened by the momentum investment system on Vetoquinol:

Vetoquinol momentum entries
  • The first momentum investment strategy would give 0.28% of return on Vetoquinol. That represents 0.81£ of latent gain with 295.19£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Vetoquinol. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

0.28 %

Latent gain

0.81 £

Invested capital

295.19 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Vetoquinol

The following chart shows the equity curve of the two momentum strategies applied to Vetoquinol:

Vetoquinol momentum equity

Note: the dividends potentially given by Vetoquinol are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Vetoquinol

The following chart shows the employed capital evolution of the two momentum strategies on Vetoquinol since the beginning:

Vetoquinol

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Vetoquinol

Buy the dip entry openings on Vetoquinol

Vetoquinol

The performance achieved by the robo-advisor on Vetoquinol is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Vetoquinol stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Vetoquinol, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Vetoquinol

The following chart shows the result of the investment strategy applied to Vetoquinol:

Vetoquinol

Note: the dividends potentially given by Vetoquinol are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Vetoquinol

The following chart shows the employed capital evolution since the beginning of the investment strategy on Vetoquinol:

Vetoquinol

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Vetoquinol

In this section, I will compare the three previous investment strategies applied to Vetoquinol.

Equity curve comparison on Vetoquinol

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Vetoquinol investment strategy comparison

Employed capital comparison on Vetoquinol

Vetoquinol investment comparison

Performance comparison on Vetoquinol

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0.0% 0.0£ 296.0£ 0.0%
Momentum 1 quarter 0.28% 0.81£ 295.19£ 7.0%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Vetoquinol:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Vetoquinol and the other stocks. There may be false positives or some missing correlated stocks. If the price of Vetoquinol does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Vetoquinol
Country France
City Lure
Address Magny-Vernois
Phone 33 3 84 62 55 55
Website www.vetoquinol.com
FullTime employees 2621
Industry
Sector
Exchange XLON
Ticker 0O1O.XLON
Market www.londonstockexchange.com

Vetoquinol ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown